" class="no-js "lang="en-US"> Se Hwan Yang - Medtech Alert
Tuesday, September 16, 2025
Se Hwan Yang

Se Hwan Yang

About Se Hwan Yang

Dr. Se Hwan Yang founded NeoImmuneTech in January 2014. Dr. Yang has created several intellectual-property protected inventions, including the hyFc® platform technology and NT-I7 drug candidate. Prior to his position at NIT, Dr. Yang was Genexine’s Head of Research Institute and Business Division from 2007 to 2014 and has served as a BOD member of Genexine. He received his Ph.D. from Pohang University of Science and Technology and has over 20 years of experience in research, product development and business in life sciences, including molecular biology, immunology and protein engineering.

Related Story

NeoImmuneTech's NT-I7 Creates a More Immunogenic Tumor Microenvironment when Associated with Pembrolizumab

September 12 2022

NeoImmuneTech, Inc. (NIT), a T cell-focused therapeutics company, presented data that suggests that NT-I7 plus […]